Improving SARS-CoV-2 viability/residual infectivity assessment from environmental samples (focus on aerosol exposure)

How can SARS CoV 2 viability/infectivity assessment find in vitro models that perform better (eg. in term of sensitivity) than cytopathic Vero E6 assays? Are there cell models expressing ACE2...

01 January 1970 7,670 2 View